Indivior reaches $600 million resolution with FTC, DOJ, state attorneys general over Suboxone
Indivior will pay $600 million to settle civil and criminal allegations that it engaged in a scheme to illegally boost sales of its opioid treatment Suboxone. The company said today it...To view the full article, register now.
Already a subscriber? Click here to view full article